Open Forum Infectious Diseases

@OFIDJournal · joined 25 Feb 2022

Open Forum Infectious Diseases publishes clinical, translational, and basic research in a fully open access, online journal. An official journal of @IDSAinfo

15 931Followers

9Following

3 656Posts total

6.2KViews on collected posts

Postingan terbaru

Open Forum Infectious Diseases@OFIDJournal7 Sep

Non-invasive sampling reveals distinct HPV and immune signatures associated with abnormal cytology in people living with HIV ✅ Just Accepted 🔗 https://t.co/EzspCx4KRw https://t.co/0Y9ZK85Q3v 247 views · 0 likes · 0 reposts · 0 replies Open on X →

Open Forum Infectious Diseases@OFIDJournal7 Sep

Efficacy and Safety of Pritelivir Versus Foscarnet for the Treatment of Acyclovir-Refractory Herpes Simplex Virus Infection in Immunocompromised Adults: A Randomized, Open-Label Phase 2 Trial ✅ Just Accepted 🔗 https://t.co/bnYAzDD508 https://t.co/YFG2VDSt1q 361 views · 7 likes · 3 reposts · 0 replies Open on X →

Open Forum Infectious Diseases@OFIDJournal6 Sep

A Retrospective Analysis Examining the Impact of Educational Attainment and Social Determinants of Health on Rifampicin-Resistant Tuberculosis Treatment Outcomes ✅ Just Accepted ✍️ @CAPRISAofficial 🔗 https://t.co/baaukVrj6d https://t.co/yT7yuP9Md2 633 views · 4 likes · 1 reposts · 0 replies Open on X →

Open Forum Infectious Diseases@OFIDJournal6 Sep

Histoplasmosis in Pregnancy: A Review and Patient Perspective ✅ Just Accepted ⭐ Editor's Choice 🔗 https://t.co/SorYlOSInn https://t.co/lC4kHojfiQ 763 views · 17 likes · 6 reposts · 0 replies Open on X →

Open Forum Infectious Diseases@OFIDJournal5 Sep

Longitudinal Outcomes of Dolutegravir-based Antiretroviral Therapy in a Large Nigerian Programmatic HIV Cohort, 2017–2019 ✅ Just Accepted ⭐ Editor's Choice 🔗 https://t.co/T4z6Etk2bh https://t.co/IdfChLawUz 2.8K views · 4 likes · 3 reposts · 0 replies Open on X →

Open Forum Infectious Diseases@OFIDJournal4 Sep

IMPAACT 2041: Designing the Study of Glecaprevir/Pibrentasvir Treatment During Pregnancy ✅ Just Accepted 🔗 https://t.co/kNPuohliGJ https://t.co/TKXB7Zy5FR 564 views · 1 likes · 0 reposts · 0 replies Open on X →

Open Forum Infectious Diseases@OFIDJournal4 Sep

My Hospital Journey with Histoplasmosis During Pregnancy ✅ Just Accepted ⭐ Editor's Choice 🔗 https://t.co/E29Xq4yQ7C https://t.co/ffwr3soyOh 810 views · 7 likes · 2 reposts · 0 replies Open on X →

Dibandingkan akun berukuran sama

7 postingan dari 90 hari terakhir, dibandingkan dengan rentang 10K–100K pengikut. jangkauan biasa untuk ukurannya, reaksi lebih lemah dari kebanyakan.

Median tayangan633akun ini924median untuk 10K–100K

Jangkauan, %3.97%akun ini3.62%median untuk 10K–100K

Interaksi, %0.79%akun ini1.52%median untuk 10K–100K

Metrik	Akun ini	Median untuk 10K–100K	Rasio
Median tayangan per postingan	633	924	0.69×
Jangkauan (tayangan ÷ pengikut)	3.97%	3.62%	1.10×
Tingkat interaksi	0.79%	1.52%	0.52×

Akun lain pada rentang ini → Bandingkan dengan akun lain → Bagaimana tolok ukur ini disusun →

Growth & engagement

How the posts we collected actually performed: views and reaction rate post by post, what the audience did with them, and where the follower count goes.

Views per post

8104 Sep

564

2.8K5 Sep

7636 Sep

633

3617 Sep

247

Last 7 collected posts, oldest on the left. The scale is logarithmic: one post can outrun the rest a hundred times over.

Engagement rate per post

1.11%4 Sep

0.18%

0.28%5 Sep

3.01%6 Sep

0.79%

2.77%7 Sep

0.00%

Reactions — likes, reposts, replies and quotes — divided by views. Median for 10K–100K accounts is 1.52%.

What the audience does

Likes60.6%40 in total

Reposts22.7%15 in total

Quotes1.5%1 in total

Bookmarks15.2%10 in total

Share of every reaction we collected for this account. Replies mean argument, reposts mean endorsement, bookmarks mean the post was worth keeping.

Followers by day

6 Sep

Daily snapshots since 06 Sep 2026; the dashed line is the starting count.